Tumor Dissociation of Highly Viable Cell Suspensions for Single-cell Omic Analyses in Mouse Models of Breast Cancer
Overview
Biomedical Engineering
Science
Affiliations
Cell preparation with a high rate of viable cells is required to obtain reliable single-cell transcriptomic and epigenomic data. This protocol describes a technique for digestion and single-cell isolation from mouse mammary tumors to achieve ∼90% of viable cells, which can be subsequently processed in a diverse array of high-throughput single-cell "omic platforms," both in an unbiased manner or after selection of a specific cell population. For complete details on the use and execution of this protocol, please refer to Valdes-Mora et al. (2021).
Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues.
Colino-Sanguino Y, Rodriguez de la Fuente L, Gloss B, Law A, Handler K, Pajic M Heliyon. 2024; 10(17):e37185.
PMID: 39296129 PMC: 11408078. DOI: 10.1016/j.heliyon.2024.e37185.
Programming tumor evolution with selection gene drives to proactively combat drug resistance.
Leighow S, Reynolds J, Sokirniy I, Yao S, Yang Z, Inam H Nat Biotechnol. 2024; .
PMID: 38965430 DOI: 10.1038/s41587-024-02271-7.
Ke C, Wu H, Wang Y, Huang W, Lin C Biomedicines. 2024; 12(4).
PMID: 38672200 PMC: 11047836. DOI: 10.3390/biomedicines12040846.
Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN.
Toufektchan E, Dananberg A, Striepen J, Hickling J, Shim A, Chen Y Cancer Immunol Res. 2024; 12(6):673-686.
PMID: 38408184 PMC: 11148545. DOI: 10.1158/2326-6066.CIR-23-1093.
Ma W, Wei S, Li Q, Zeng J, Xiao W, Zhou C Mol Cancer Ther. 2024; 23(5):700-710.
PMID: 38237027 PMC: 11065592. DOI: 10.1158/1535-7163.MCT-23-0458.